Fluarix Tetra

Fluarix Tetra is an influenza vaccine designed to protect against four strains of the flu virus. This vaccine is administered intramuscularly and is manufactured by Glaxosmithkline Biologicals S.A.

Fluarix Tetra is used to prevent influenza caused by the B/Phuket/3073/2013-Like Virus and Influenza Virus B/Austria/1359417/2020. It is typically administered annually to help reduce the risk of flu infection and its complications. This vaccine is part of a broader strategy to manage seasonal flu outbreaks.

Common effects of Fluarix Tetra may include soreness at the injection site, mild fever, and muscle aches. These effects are generally mild and short-lived. Severe reactions are rare but can occur, and individuals should seek medical attention if they experience unusual symptoms.

Fluarix Tetra should be administered with caution in individuals with a history of severe allergic reactions to previous influenza vaccines. It is important to inform healthcare providers about any allergies or medical conditions before receiving the vaccine. Follow the recommended storage and handling guidelines to ensure the vaccine's effectiveness.

Fluarix Tetra may interact with certain medications or other vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving Fluarix Tetra. Alcohol and other substances that affect the immune system may also influence the vaccine's effectiveness.